Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2022 May 21;71(9):2183–2184. doi: 10.1007/s00262-022-03218-0

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors

Mitchell S von Itzstein 1,2, Amrit S Gonugunta 3, Yiqing Wang 4, Thomas Sheffield 4, Rong Lu 4,7, Sadia Ali 5, Farjana J Fattah 2, Donglu Xie 6, Jennifer Cai 6, Yang Xie 2,4, David E Gerber 1,2,4,
PMCID: PMC9374621  PMID: 35596002

Correction to: Cancer Immunology, Immunotherapy 10.1007/s00262-022-03151-2

The article Divergent prognostic effects of pre‑existing and treatment‑emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors, written by Mitchell S. von Itzstein, Amrit S. Gonugunta, Yiqing Wang, Thomas Sheffield, Rong Lu, Sadia Ali, Farjana J. Fattah, Donglu Xie, Jennifer Cai, Yang Xie and David E. Gerber, was originally published electronically on the publisher’s internet portal on 24 January 2022 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 26 April 2022 to © The Author(s) 2021 and this article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES